Researchers from University Magna Graecia of Catanzaro demonstrate the importance of evaluating #eyemovements in patients with in Progressive Supranuclear Palsy #PSP and its potential for differential diagnosis with #Parkinson's disease. https://t.ly/RZYwu
About us
NeuraLight is developing a software-based platform for eye movement analysis, providing an objective and sensitive tool in neurodegenerative diseases. Our platform is successfully used in several CNS clinical trials, presenting the ability of using eye movement analysis to differentiate patients from healthy subjects, stratify different subgroups, and monitor disease progression.
- Website
-
http://www.neuralight.ai
External link for NeuraLight
- Industry
- Software Development
- Company size
- 11-50 employees
- Headquarters
- Tel Aviv
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
Tel Aviv, IL
Employees at NeuraLight
Updates
-
Since it was first described in 1817 by James Parkinson as a "shaking palsy," diagnosis of #parkinson's disease still remains a challenge. Thank you Jeffrey Kluger from TIME magazine for this interesting article! https://t.ly/65qYT
How Is Parkinson’s Disease Diagnosed?
time.com
-
Today, July 22nd is #worldbrainday, aimed at promoting awareness and education for #neurological disorders. We at NeuraLight support this important topic, using #eyemovements to improve patients' assessment and monitoring during their struggle to find cure and better care #wbd2024
-
A new research from the Universidad Nacional Autónoma de México in early patients with #Huntington's Disease revealed abnormalities in saccadic, pupil, and blink #eyemovements, suggestive of brain circuitry abnormalities that probably involve brain stem deficits. https://t.ly/u0w2e
-
A new systematic review in Frontiers on abnormal #movements in motor neuron disease, quoting the recent work of researchers who used NeuraLight platform to compare patients with #als to healthy controls. https://t.ly/0lG99
Frontiers | Oculomotor atypicalities in motor neurone disease: a systematic review
frontiersin.org
-
We are thrilled to announce that our recent work on using NeuraLight #eyemovements platform as a #biomarker to follow disease progression in a drug trial of #ALS patients was just published! https://t.ly/pW5KW
Changes in saccadic intrusions over time as an objective biomarker to follow ALS disease progression
tandfonline.com
-
#Eyemovements have long been recognized as a valuable indicator of neurological conditions. Read this newly published mini-review from NeuraLight team in Frontiers, emphasizing their potential use in assessing patient conditions and disease progress. https://t.ly/YevMd
Frontiers | Advancements in Eye Movement Measurement Technologies for Assessing Neurodegenerative Diseases
frontiersin.org
-
A nice new review on how #eyemovements in #Parkinson's disease can be a promising tool for early diagnosis https://t.ly/WMdOy
Deciphering Parkinson’s Disease through Eye Movements: A Promising Tool for Early Diagnosis in the Face of Cognitive Impairment
onlinelibrary.wiley.com
-
#eyemovements are known for decades as "a window to the brain". This newly published paper in PLOS provides interesting insights of their correlation with #fMRI results. https://t.ly/Ta1rP
Exploring oculomotor functions in a pilot study with healthy controls: Insights from eye-tracking and fMRI
journals.plos.org
-
Today, June 21st is the Motor Neurone Disease #MND Awareness Day! Read this review in Frontiers on abnormalities of #eyemovements in #ALS. https://t.ly/-qfEz
Frontiers | Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement
frontiersin.org